Second CRISPR-Modified Pregnancy May Be Underway

He Jiankui, who reportedly edited the genomes of two babies already, broke the news at a conference in Hong Kong.

Written byAshley P. Taylor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, ROST-9D

He Jiankui, the scientist who claims to have used CRISPR to edit the genomes of twin girls born earlier this month, announced today (November 28) at a conference in China that a second pregnancy with a CRISPR-modified embryo is progress, the Associated Press reports.

“This is a truly unacceptable development,” Jennifer Doudna, the University of California, Berkeley, RNA biologist who co-invented CRISPR-based gene editing, tells the AP.

“I feel more disturbed now,” adds David Liu of Harvard and MIT’s Broad Institute who invented a form of CRISPR that allows for base editing. “It’s an appalling example of what not to do about a promising technology that has great potential to benefit society. I hope it never happens again.”

Speaking at the Second International Summit On Human Genome Editing in Hong Kong, He, a professor at the Southern University of Science and Technology in Shenzhen, said that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies